Loading...
You are viewing a DELETED record.
This record information is displayed for reference purpose only and should be not used.
This document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Biosafety Expert
(EXP)
last updated: 30 Nov 2023
Didier BREYER received his Ph.D. in Biology from the University of Liège (Belgium) in 1989 and conducted academic research activities for 6 years in the field of molecular biology. Since 1995 he has been working as senior scientist in the Biosafety and Biotechnology Unit (SBB) of the Scientific Institute of Public Health (Brussels, Belgium). He is involved mainly in the scientific evaluation and administrative follow-up of biosafety dossiers, providing scientific support to the Biosafety Advisory Council and the Belgian Competent Authorities. He is also involved in communication activities including publication of scientific papers, oral presentations, participation in research projects, and the development and management of web-based information exchange mechanisms (in particular http://www.biosafety.be). He has been active in various international bodies acting in the field of biosafety (in particular the OECD) and is currently appointed as Belgian Focal Point for the Biosafety Clearing-House of the Cartagena Protocol.
EN
Person:Dr Didier BreyerRue Juliette Wytsmanstraat 14Brussels,
B-1050, BelgiumPhone: +32 478 293078,Fax: +32 2 642 52 92,Email: didier.breyer@wiv-isp.be,Website: http://www.iph.fgov.be,
1962
- Belgian
Sciensano
EN
Government agency (National/Federal)
Scientific expert
EN
Biosafety and Biotechnology Unit (SBB)
EN
1995-02-06-01
Government agency (National/Federal)
- Supervising the scientific expertise and the secretariat in the framework of the activities of the Belgian Biosafety Advisory Council.
- Drafting a wide variety of texts (legislative and policy proposals, background papers, advices, scientific publications and recommendations) for competent authorities and partners involved in biosafety matters.
- Scientific evaluation and administrative follow-up of regulatory dossiers relating to the use of genetically modified and/or pathogenic organisms in contained facilities, to the environmental release of GMOs and to the placing on the EU market of GMOs and derived products.
- National Focal Point for the "Biosafety Clearing-House" (BCH) of the Cartagena Protocol on Biosafety.
- Scientific support to the Belgian delegation at EU level (Council, Commission) and in various international Fora (United Nations, OECD) within the framework of the negotiation or implementation of EU legislation and international agreements relating to biosafety and GMO.
- Participation in European and Belgian research projects.
- Public information in the field of biosafety, in particular via Internet.
EN
- Belgium
University of Liège, Belgium (ULg)
EN
Laboratory of Pharmacology, Institute of Pathology
EN
1990-03-02-01
1993-09-30-01
Academic or research institute
- Basic and applied research activities in the laboratory, using molecular and cell biology techniques for the production of therapeutic molecules.
- Supervision of 3 staff.
- Teaching to undergraduates.
EN
B.Sc. in Biological Sciences
EN
University of Liège, Belgium
EN
1980-10-01-01
1982-07-15-01
M.Sc. in Botanical Sciences
EN
University of Liège, Belgium
EN
1982-10-01-01
1984-09-15-01
M.Sc. in Botanical Sciences
EN
University of Liège, Belgium
EN
1982-10-01-01
1984-09-15-01
B. Other professional qualifications
- Certification in Computer analysis and programming (Bull S.A., Belgium, 1994)
- Biosafety systems development and implementation expertise
- Biosafety Clearing-House operations
- Public information/ communications
- Risk assessment and risk management
- Breyer D., Kopertekh L. and Reheul D. 2014. Alternatives to Antibiotic Resistance Marker Genes for In Vitro Selection of Genetically Modified Plants - Scientific Developments, Current Use, Operational Access and Biosafety Considerations. Critical Reviews in Plant Sciences 33(4):286-330.
- Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge? D. Breyer, P. Herman, A. Brandenburger, G. Gheysen, E. Remaut, P. Soumillion, J. Van Doorsselaere, R. Custers, K. Pauwels, M. Sneyers and D. Reheul Environ. Biosafety Res. 2009, 8, 57-64
- Biosafety considerations associated with molecular farming in genetically modified plants Didier Breyer, Martine Goossens, Philippe Herman and Myriam Sneyers Journal of Medicinal Plants Research, 2009, 3(11), 825-838
- From 1998 to 2004, I have been member of the OECD Working Group on Harmonization of Regulatory Oversight in Biotechnology.
- Working Group "New Techniques" of the European Commission. Representing Belgium in this WG, which shall evaluate a list of new techniques for which it is unclear whether they result in genetic modification and address whether these techniques lead to GMOs as defined under European Directives 2001/18/EC and 90/219/EEC.
- Member of the expert database set up by EFSA to assist its Scientific Committee, Scientific Panels, EFSA networks and respective working groups.
- French
| Language | Level |
|---|---|
| English | excellent |
| French | excellent |
Nomination Type
Open-ended Online Expert Forum on RA&RM
Birth Place
Charleroi
Other Publications
http://www.biosafety.be/SBB/SBB_3.html
Other Publications links
| Name | Url |
| Breyer Didier: List Scientific Publications | https://bch.cbd.int/database/attachment/?id=14854 |
- Scientific Institute of Public Health [ English ]
